FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41085911000001107: Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2463971000001112 Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2463981000001114 Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Is a Upadacitinib 45mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has AMP Rinvoq 45mg modified-release tablets (AbbVie Ltd) true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Upadacitinib hemihydrate true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start